Outcomes of a Program to Reduce Birth-Related Mortality in Tanzania
N Engl J Med. 2025 Feb 26. doi: 10.1056/NEJMoa2406295. Online ahead of print. ABSTRACT BACKGROUND: Birth-related mortality is a major contributor to the burden of …
Month: February 2025
Management of Zygomaticomaxillary Complex Fractures in Children
J Craniofac Surg. 2025 Feb 26. doi: 10.1097/SCS.0000000000011185. Online ahead of print. ABSTRACT OBJECTIVE: Zygomaticomaxillary complex (ZMC) fractures in children can lead to severe aesthetic …
A Multicenter Training and Interrater Reliability Study of the BASED Score for Infantile Epileptic Spasms Syndrome
J Clin Neurophysiol. 2025 Mar 1;42(3):230-234. doi: 10.1097/WNP.0000000000001101. Epub 2024 Jul 11. ABSTRACT PURPOSE: The best possible outcomes in infantile epileptic spasms syndrome require electroclinical …
Safety of Onasemnogene Abeparvovec Administration to Type 1 SMA Patients Who Have Received Risdiplam
J Clin Neuromuscul Dis. 2025 Mar 1;26(3):140-147. doi: 10.1097/CND.0000000000000521. ABSTRACT Three therapies are now available for the treatment of type 1 spinal muscular atrophy: onasemnogene …
Administration of Milrinone Following Tetralogy of Fallot Repair Increases Postoperative Volume Administration Without Improving Cardiac Output
Anesth Analg. 2023 Nov 1;137(5):1056-1065. doi: 10.1213/ANE.0000000000006662. Epub 2023 Oct 20. ABSTRACT BACKGROUND: Phosphodiesterase inhibitors are known to relieve symptoms in the setting of heart …
Effect of empagliflozin treatment on laboratory and clinical findings of patients with glycogen storage disease type Ib: first study from Türkiye
J Pediatr Endocrinol Metab. 2025 Feb 27. doi: 10.1515/jpem-2024-0556. Online ahead of print. ABSTRACT OBJECTIVES: Empagliflozin has been used for the treatment of over 100 …
Equity in Neonatal Intestinal Failure-No Organ Left Behind
JAMA Netw Open. 2025 Feb 3;8(2):e2459507. doi: 10.1001/jamanetworkopen.2024.59507. NO ABSTRACT PMID:40009388 | DOI:10.1001/jamanetworkopen.2024.59507
Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1 With MEK Inhibitor Selumetinib: A Nonrandomized Clinical Trial
JAMA Dermatol. 2025 Feb 26. doi: 10.1001/jamadermatol.2024.6574. Online ahead of print. ABSTRACT IMPORTANCE: Cutaneous neurofibromas (cNFs) can cause itching, disfigurement, pain, and emotional difficulties in …
Social and Financial Costs of Neonatal Intestinal Failure
JAMA Netw Open. 2025 Feb 3;8(2):e2459548. doi: 10.1001/jamanetworkopen.2024.59548. ABSTRACT IMPORTANCE: Neonatal short bowel syndrome with intestinal failure is rare, and observational studies are limited to …
Genetic Variants and Clinical Features of Patients With Glycogen Storage Disease Type Ib
JAMA Netw Open. 2025 Feb 3;8(2):e2461888. doi: 10.1001/jamanetworkopen.2024.61888. ABSTRACT IMPORTANCE: Glycogen storage disease type Ib (GSDIb) is a rare metabolic disorder characterized by impaired glucose-6-phosphate …